Aflibercept

被引：76

作者：

Stewart, Michael W. ^{[1
]}

Grippon, Seden ^{[2
]}

Kirkpatrick, Peter

机构：

[1] Mayo Clin, Mayo Med Sch, Dept Ophthalmol, Jacksonville, FL 32224 USA

[2] IMS Hlth, London NW1 6JB, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2012年 / 11卷 / 04期

关键词：

RANIBIZUMAB;

D O I：

10.1038/nrd3700

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Fusion protein that inhibits vascular endothelial growth factor signalling approved in the United States for the treatment of neovascular age-related macular degeneration.

引用

页码：269 / 270

页数：2

共 5 条

[1] VEGF-Trap: A VEGF blocker with potent antitumor effects [J].

Holash, J ;

Davis, S ;

Papadopoulos, N ;

Croll, SD ;

Ho, L ;

Russell, M ;

Boland, P ;

Leidich, R ;

Hylton, D ;

Burova, E ;

Ioffe, E ;

Huang, T ;

Radziejewski, C ;

Bailey, K ;

Fandl, JP ;

Daly, T ;

Wiegand, SJ ;

Yancopoulos, GD ;

Rudge, JS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) :11393-11398

[2] Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group [J].

Martin, Daniel F. ;

Maguire, Maureen G. ;

Ying, Gui-shuang ;

Grunwald, Juan E. ;

Fine, Stuart L. ;

Jaffe, Glenn J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (20) :1897-1908

[3] Fresh from the pipeline - Ranibizumab [J].

Narayanan, Raja ;

Kuppermann, Baruch D. ;

Jones, Carole ;

Kirkpatrick, Peter .

NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (10) :815-816

[4] The Expanding Role of Vascular Endothelial Growth Factor Inhibitors in Ophthalmology [J].

Stewart, Michael W. .

MAYO CLINIC PROCEEDINGS, 2012, 87 (01) :77-88

[5]

US Food and Drug Administration, 2011, FDA LAB INF EYL

← 1 →